Assembly Biosciences, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Assembly Biosciences, Inc. (ASMB) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$12.46 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-09
- Assembly Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$19.12M, a 384.72% decline year-over-year.
- Assembly Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $6.66M, a 166.54% increase year-over-year.
- Assembly Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $15.67M.
- Assembly Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $11.32M.
- Assembly Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $36.20M.
- Assembly Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$64.86M, a 23479.70% decline from fiscal 2014.
- Assembly Biosciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $277.40K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$19.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$12.46M 10-Q · filed 2017-08-09 | $3.21M derived: sum of 3 quarters · filed 2017-08-09 | $14.53M derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | $6.66M 10-Q · filed 2017-05-08 | $22.33M derived: sum of 2 quarters · filed 2017-05-08 | $33.64M derived: sum of 3 quarters · filed 2017-05-08 | $40.36M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-12-31 | $15.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $26.98M derived: sum of 2 quarters · filed 2017-03-02 | $33.70M derived: sum of 3 quarters · filed 2017-08-09 | $36.20M 10-K · filed 2017-03-02 |
| 2016-09-30 | $11.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $18.03M derived: sum of 2 quarters · filed 2017-08-09 | $20.53M 10-Q · filed 2016-11-09 | $16.69M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-06-30 | $6.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $9.21M 10-Q · filed 2017-08-09 | $5.37M derived: sum of 3 quarters · filed 2017-08-09 | -$6.81M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $2.50M 10-Q · filed 2017-05-08 | -$1.34M derived: sum of 2 quarters · filed 2017-05-08 | -$13.53M derived: sum of 3 quarters · filed 2017-05-08 | -$62.33M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | -$3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$16.03M derived: sum of 2 quarters · filed 2017-03-02 | -$64.82M derived: sum of 3 quarters · filed 2017-03-02 | -$64.86M 10-K · filed 2017-03-02 |
| 2015-09-30 | -$12.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$60.99M derived: sum of 2 quarters · filed 2016-11-09 | -$61.02M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$48.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$48.83M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$30.71K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $277.40K 10-K · filed 2017-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |